In The News Raging At The Pandemic, A VC Raises $800M For A Company That Aims To Transform Biotech Manufacturing The board of the new company, Resilience, includes a who’s who of former industry and government officials. Click here to read the original article in STAT.
Press Release Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates The facility expands Resilience’s global footprint and represents the first GMP biopharma facility in the region based in the UAE Read on
Press Release Resilience Announces Collaboration To Manufacture And Deliver Biotherapeutics For Rare And Complex Conditions Collaboration includes build of embedded process and analytical development labs for use by Mayo Clinic and third-party biotech companies to advance... Read on
Press Release Resilience Receives USD $164 Million Investment From The Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness SAN DIEGO & BOSTON--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a company building the world’s most advanced biopharmaceutical... Read on
